BioSpace News Archive

Pharm Country

Dr. Reddy’s Laboratories Announces the Launch of a Generic Version of Sapropterin Dihydrochloride Tablets for Oral Use in the U.S. Market

Dr. Reddy’s Laboratories Ltd. announced the launch of a generic version of Sapropterin Dihydrochloride Tablets, for Oral Use.

October 3, 2020
·
3 min read
Pharm Country

Novartis announces five-year data that reinforce the safety and efficacy profile of Aimovig® (erenumab-aooe) in adult patients with episodic migraine

Five-year open-label extension study shows patients continued to experience a sustained benefit; Aimovig maintained a consistent safety profile

October 3, 2020
·
15 min read
Genetown

Apellis Announces New Analysis Demonstrating Targeted C3 Therapy Pegcetacoplan Slows Progression of Early Disease in Patients with Geographic Atrophy (GA)

Post hoc analysis of Phase 2 FILLY study shows 39% reduction in rate of progression from nascent GA, an earlier form of disease, to GAin patients treated with pegcetacoplan monthly vs. sham

October 3, 2020
·
8 min read
Biotech Beach

Amgen Announces Five-Year Data That Reinforce The Safety And Efficacy Profile Of Aimovig® (erenumab-aooe) In Adult Patients With Episodic Migraine

Five-Year Open-label Extension Study Shows Patients Continued to Experience a Sustained Benefit; Aimovig Maintained a Consistent Safety Profile

October 3, 2020
·
19 min read
Policy

Statement from the Chief Public Health Officer of Canada on October 3, 2020

In lieu of an in-person update to the media, Dr. Theresa Tam, Canada’s Chief Public Health Officer, issued the following statement

October 3, 2020
·
2 min read